Over 28K Mucormycosis Cases Reported Till Date in India by Hannah Joy on June 10, 2021 at 1:15 PM
In India, a total of 28,252 cases of mucormycosis have been reported so far from 28 states, of which 86% have a history of Covid-19 infections and 62.3% have diabetes, said the Central government.
Union Health Minister Harsh Vardhan said this while chairing the 28th meeting of the high-level Group of Ministers on Covid-19 through a video-conference, here. So far, 28,252 cases have been reported from 28 states. Out of these, 86 per cent (24,370 cases) have a history of Covid-19 infection and 62.3 per cent (17,601) have a history of diabetes.
‘Mucormycosis, a serious but rare fungal infection caused by a group of molds called mucormycetes has affected even Covid-19 patients and diabetics.’
Fully vaccinated people may soon be able to travel without RT-PCR negative report businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.
âReports of inequities completely baselessâ: Centre defends its COVID-19 vaccination policy
Photo Credit: PTI
Calling the media reports alleging vaccine inequity in India s vaccination drive as inaccurate and speculative in nature, the Centre on Saturday said liberalised pricing and accelerated national COVID-19 inoculation strategy ensures vaccine equity.
It said the vaccine policy that was launched on May 1 facilitates better access and reduces the operational stress on government vaccination facilities. A Liberalised Pricing and Accelerated National COVID-19 Vaccination Strategy was adopted on May 1, which is guiding the ongoing Phase-III of COVID-19 vaccination drive. It is reiterated that the Liberalised Vaccine policy, which envisages a larger role for the private sector and the Centre is setting aside 25 per cent of vaccines for the private sector. This mechanism facilitates better access and reduces the operational stress on Government Vaccination facil
New Delhi [India], June 6 (ANI): The Central government is mulling over a mechanism to enable hassle-free domestic air travel and to do away with the mandatory RT-PCR report for those passengers who have received both jabs of a COVID-19 vaccine.